Aramark director awarded 7,751 deferred stock units

Aramark director Stephen I. Sadove received a grant of 7,751 deferred stock units of common stock on February 3, 2026 at $38.06 per unit.

Rhea-AI Filing Summary

Aramark director Stephen I. Sadove received a grant of 7,751 deferred stock units of common stock on February 3, 2026 at $38.06 per unit. After this award, he beneficially owned 102,049.114 common shares directly and 15,000 common shares indirectly through a trust.

The deferred stock units will vest on the day before the first annual stockholders' meeting following the grant date, as long as Sadove continues his board service. If they vest, the units will be settled in Aramark common shares on the first day of the seventh month after he leaves the board.

Insider Trade Summary

Grant/Award: 7,751 shares

Grant/Award 2 txns

Insider SADOVE STEPHEN I

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	7,751	$38.06	$295K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 102,049.114 shares (Direct); Common Stock — 15,000 shares (Indirect, By Trust)

Footnotes (1)

1. F1. Represents a grant of deferred stock units, which will vest on the day prior to the first annual stockholders' meeting of the Company occurring after the grant date, subject to continued service, and, if vested, will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Aramark (ARMK) report for Stephen I. Sadove?

Aramark reported that director Stephen I. Sadove received 7,751 deferred stock units of common stock on February 3, 2026 at $38.06 per unit. These units are a form of equity compensation that convert into common shares after vesting and a deferral period.

How many Aramark (ARMK) shares does Stephen I. Sadove beneficially own after this grant?

After the grant, Stephen I. Sadove beneficially owns 102,049.114 Aramark common shares directly and 15,000 common shares indirectly through a trust. These amounts reflect his reported holdings following the February 3, 2026 equity award transaction.

How do Stephen I. Sadove’s Aramark deferred stock units vest and settle?

The 7,751 deferred stock units vest the day before the first annual stockholders’ meeting following the grant date, provided he continues serving on the board. Once vested, they are settled in Aramark common stock on the first day of the seventh month after his departure from the board.

What type of Form 4 filing did Aramark (ARMK) submit for Stephen I. Sadove?

Aramark filed a Form 4 showing an equity compensation award to director Stephen I. Sadove. The filing records an acquisition of 7,751 deferred stock units of common stock, coded as an “A” transaction, rather than an open-market purchase or sale of existing shares.

Does Stephen I. Sadove hold any Aramark (ARMK) shares indirectly?

Yes. In addition to his directly held Aramark shares, Stephen I. Sadove reports indirect beneficial ownership of 15,000 common shares through a trust. This indirect position is identified in the filing as held “By Trust” under the indirect ownership category.

Is the reported Aramark (ARMK) transaction a purchase or a grant?

The transaction is a grant of 7,751 deferred stock units to Stephen I. Sadove as director compensation, not an open-market purchase. The units are awarded at a reference price of $38.06 and convert into common shares after vesting and a specified deferral period.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/04/2026 - 04:33 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SADOVE STEPHEN I

(Last) (First) (Middle)

C/O ARAMARK

2400 MARKET STREET

(Street)

PHILADELPHIA PA 19103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/03/2026		A		7,751(1)	A	$38.06	102,049.114	D
Common Stock								15,000	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a grant of deferred stock units, which will vest on the day prior to the first annual stockholders' meeting of the Company occurring after the grant date, subject to continued service, and, if vested, will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board.

Remarks:

	/s/ Ryan S. Spengler, as Attorney-in-fact	02/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.